Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk.
about
Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 2. Fundamental Concepts in Genetic EpidemiologyGene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING StudiesWolfram syndrome: new mutations, different phenotypeDecreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study.Single-nucleotide polymorphisms in chromosome 3p14.1- 3p14.2 are associated with susceptibility of type 2 diabetes with cataract.A WFS1 haplotype consisting of the minor alleles of rs752854, rs10010131, and rs734312 shows a protective role against type 2 diabetes in Russian patients.Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus.A Challenging Form of Non-autoimmune Insulin-Dependent Diabetes in a Wolfram Syndrome Patient with a Novel Sequence Variant.Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes.Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes.Association of aggression with a novel microRNA binding site polymorphism in the wolframin gene.Recent explosive human population growth has resulted in an excess of rare genetic variants.Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells.Deep resequencing reveals excess rare recent variants consistent with explosive population growthWFS1 variants in Finnish patients with diabetes mellitus, sensorineural hearing impairment or optic atrophy, and in suicide victims.Multicapillary gel electrophoresis based analysis of genetic variants in the WFS1 gene.Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus.Association of CpG-SNP and 3'UTR-SNP of WFS1 with the Risk of Type 2 Diabetes Mellitus in an Iranian Population.Differential promoter activity by nucleotide substitution at a type 2 diabetes genome-wide association study signal upstream of the wolframin gene
P2860
Q24273406-4929AE1F-1463-44E5-8A87-C48702F6F17FQ28397345-C63CC9AE-EBC6-4CB4-BEBA-C0028DA76019Q28478694-08005C55-B82F-428D-8E5C-E571BB4E785FQ33762350-661D9240-9DEE-4A80-A6CA-5B2FCF9E1EB4Q33980583-6A423157-2C1C-4409-ADAA-836277EF5DD4Q35127946-E84C7D41-3A75-43D1-843D-0B7A59A60AA1Q35795038-F5E595CC-F00E-4049-BB32-98AE812FB2C1Q36497640-DEE718A4-A97E-46CF-B6CC-547A417BF2E2Q36651827-18A16457-D7F8-4672-9503-933C0CDD398AQ36960085-3CADC96A-E4A3-424F-9EC6-52F09DD53BD6Q38180221-638BF9BE-4D56-4D92-8FA3-67DF219DEF35Q38315746-156266B7-802F-4F05-A8F7-6A8C0F38BB01Q41667582-2E709B2F-BC9C-4BD2-8FF2-C53F62377E2AQ41689677-5D25F59B-BE84-456A-B9CB-8837C32B7679Q42700588-CB2E71E1-738A-4E2B-90CF-5E98DCF223B8Q44793653-1F58B1C5-08BD-4F9A-94A9-C79287498172Q51664320-C308FEC0-F9DF-4532-84E3-2C9E0F97D210Q51726149-30D8F7BC-47E5-4CCC-BDC1-61A4E7C5A99AQ55475171-669E9B23-B6D9-493A-8D99-C3AB5D52AA33Q59293896-ECFF0E83-EBCA-43D0-B38B-CFF9AB10506E
P2860
Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Detailed investigation of the ...... iants in type 2 diabetes risk.
@ast
Detailed investigation of the ...... iants in type 2 diabetes risk.
@en
type
label
Detailed investigation of the ...... iants in type 2 diabetes risk.
@ast
Detailed investigation of the ...... iants in type 2 diabetes risk.
@en
prefLabel
Detailed investigation of the ...... iants in type 2 diabetes risk.
@ast
Detailed investigation of the ...... iants in type 2 diabetes risk.
@en
P2093
P2860
P50
P356
P1433
P1476
Detailed investigation of the ...... iants in type 2 diabetes risk.
@en
P2093
Alan Permutt
Allan Daly
Andrew P Morris
Jon Wasson
Manjinder S Sandhu
Olov Rolandsson
Sally L Ricketts
P2860
P304
P356
10.2337/DB09-0920
P407
P50
P577
2009-12-22T00:00:00Z